Therapy Analysis & Statistics, June 2014 (p20)

24/7 Customer Support

Talk to Louis

+1 718 618 4302

All regions

You might be interested in: therapeutics, biotherapeutics, cancer therapeutics, more »

571-600 of about 2 200 reports

Purchase Reports From Reputable Market Research Publishers

Cellectar Biosciences, Inc. (CLRB) - Financial and Strategic SWOT Analysis Review

Cellectar Biosciences, Inc. (CLRB) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • June 2014
  • by Global Data

Cellectar Biosciences, Inc. (CLRB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled ...

  • Industries : Therapy
Inhaled COPD Therapeutics Market

Inhaled COPD Therapeutics Market

  • $ 3 850
  • Industry report
  • June 2014
  • by Greystone Research Associates

COPD is not one but a family of conditions, each with its own etiology and treatment challenges. Chronic bronchitis is the inflammation and eventual scarring of the lining of the bronchial tubes. Oral ...

  • Industries : Therapy
Inhaled Asthma Therapeutics Market

Inhaled Asthma Therapeutics Market

  • $ 3 850
  • Industry report
  • June 2014
  • by Greystone Research Associates

Asthma continues to be a health segment with significant incidence and morbidity. There has been significant interest directed toward the development easier-to-use inhalers, primarily because a large segment ...

  • Industries : Therapy
Inhaled CNS Therapeutics Market

Inhaled CNS Therapeutics Market

  • $ 2 850
  • Industry report
  • June 2014
  • by Greystone Research Associates

Neurological disorders are highly prevalent worldwide. And while mental and neurological disorders are responsible for about one per cent of deaths, they account for almost 11 per cent of disease burden ...

  • Industries : Therapy
Breast Cancer Therapeutics in Major Developed Markets to 2020 - Approval of Novel Therapies to Support Continued Dominance of HER2 Targeted Drugs

Breast Cancer Therapeutics in Major Developed Markets to 2020 - Approval of Novel Therapies to Support Continued Dominance of HER2 Targeted Drugs

  • $ 3 500
  • Industry report
  • June 2014
  • by GBI Research

Breast Cancer Therapeutics in Major Developed Markets to 2020 - Approval of Novel Therapies to Support Continued Dominance of HER2 Targeted Drugs Summary GBI Research, the leading business intelligence ...

  • Industries : Therapy
  • Countries : World
Antihypertensive Therapeutics in Major Developed Markets to 2020 - Increased Uptake of Combination Therapies to Offset Effects of Key Patent Expiries

Antihypertensive Therapeutics in Major Developed Markets to 2020 - Increased Uptake of Combination Therapies to Offset Effects of Key Patent Expiries

  • $ 3 500
  • Industry report
  • June 2014
  • by GBI Research

Antihypertensive Therapeutics in Major Developed Markets to 2020 - Increased Uptake of Combination Therapies to Offset Effects of Key Patent Expiries Summary GBI Research, the leading business intelligence ...

  • Industries : Therapy
  • Countries : World
Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany

Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany

  • $ 3 500
  • Industry report
  • June 2014
  • by GBI Research

Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany Summary GBI Research, a leading business ...

  • Industries : Therapy
  • Countries : World, Germany, Japan, United States, Europe, North America, Canada, Spain, Italy, France, United Kingdom
Global Proton Therapy Outlook 2018

Global Proton Therapy Outlook 2018

  • $ 2 000
  • Industry report
  • June 2014
  • by RNCOS

Proton Therapy, the new kid on the block for cancer treatment, has garnered worldwide attention in the past few years. Due to its ability to deliver higher doses of radiation to the targeted areas without ...

  • Industries : Therapy
  • Countries : Germany, China, Japan, World
 Uveitis- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Uveitis- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • June 2014
  • by Delve Insight

DelveInsight's, “ Uveitis- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed drugs ...

  • Industries : Therapy
  • Countries : United States, World
 Women Infertility- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Women Infertility- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • June 2014
  • by Delve Insight

DelveInsight's, “ Women Infertility- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed ...

  • Industries : Therapy
  • Countries : United States, World
 Malaria- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Malaria- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • June 2014
  • by Delve Insight

DelveInsight's, “ Malaria- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed drugs ...

  • Industries : Therapy
  • Countries : United States, World
 Anthrax- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Anthrax- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • June 2014
  • by Delve Insight

DelveInsight's, “ Anthrax- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed drugs ...

  • Industries : Therapy
  • Countries : United States, World
 Genital Herpes- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Genital Herpes- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • June 2014
  • by Delve Insight

DelveInsight's, “ Genital Herpes- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed ...

  • Industries : Therapy
  • Countries : United States, World
 Inflammation- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Inflammation- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • June 2014
  • by Delve Insight

DelveInsight's, “ Inflammation- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed ...

  • Industries : Therapy
  • Countries : United States, World
 Mania- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Mania- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • June 2014
  • by Delve Insight

DelveInsight's, “ Mania- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed drugs ...

  • Industries : Therapy
  • Countries : United States, World
Neuropathic Pain- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Neuropathic Pain- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • June 2014
  • by Delve Insight

DelveInsight's, “ Neuropathic Pain- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed ...

  • Industries : Therapy
  • Countries : United States, World
 Glaucoma- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Glaucoma- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • June 2014
  • by Delve Insight

DelveInsight's, “ Glaucoma- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed drugs ...

  • Industries : Therapy
  • Countries : United States, World
 Melanoma- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Melanoma- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • June 2014
  • by Delve Insight

DelveInsight's, “ Melanoma- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed drugs ...

  • Industries : Therapy
  • Countries : United States, World
 Pulmonary Arterial Hypertension- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Pulmonary Arterial Hypertension- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • June 2014
  • by Delve Insight

DelveInsight's, “ Pulmonary Arterial Hypertension- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline ...

  • Industries : Therapy
  • Countries : United States, World
 Skin And Skin Structure Infections by S.Pneumoniae- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Skin And Skin Structure Infections by S.Pneumoniae- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • June 2014
  • by Delve Insight

DelveInsight's, “ Skin And Skin Structure Infections by S.Pneumoniae- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about ...

  • Industries : Therapy
  • Countries : United States
 Insomnia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Insomnia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • June 2014
  • by Delve Insight

DelveInsight's, “ Insomnia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed drugs ...

  • Industries : Therapy
  • Countries : United States, World
 Skin And Soft Tissue Infections- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Skin And Soft Tissue Infections- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • June 2014
  • by Delve Insight

DelveInsight's, “ Skin And Soft Tissue Infections- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline ...

  • Industries : Therapy
  • Countries : United States
Acute Pain- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Acute Pain- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • June 2014
  • by Delve Insight

DelveInsight's, “ Acute Pain- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed ...

  • Industries : Therapy
  • Countries : United States, World
 Asthma- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Asthma- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • June 2014
  • by Delve Insight

DelveInsight's, “ Asthma- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed drugs ...

  • Industries : Therapy
  • Countries : United States, World
 Bronchospasm- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Bronchospasm- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • June 2014
  • by Delve Insight

DelveInsight's, “ Bronchospasm- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed ...

  • Industries : Therapy
  • Countries : United States, World
Dental Pain- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Dental Pain- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • June 2014
  • by Delve Insight

DelveInsight's, “ Dental Pain- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed ...

  • Industries : Therapy
  • Countries : United States, World
 Burns- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Burns- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • June 2014
  • by Delve Insight

DelveInsight's, “ Burns- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed drugs ...

  • Industries : Therapy
  • Countries : United States, World
 Gram-Negative Bacterial Infections- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Gram-Negative Bacterial Infections- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • June 2014
  • by Delve Insight

DelveInsight's, “ Gram-Negative Bacterial Infections- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline ...

  • Industries : Therapy
  • Countries : United States, World
 Migraine- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Migraine- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • June 2014
  • by Delve Insight

DelveInsight's, “ Migraine- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed drugs ...

  • Industries : Therapy
  • Countries : United States, World
Cancer Pain- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Cancer Pain- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • June 2014
  • by Delve Insight

DelveInsight's, “ Cancer Pain- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed ...

  • Industries : Therapy
  • Countries : United States, World
About 700 reports

Download Unlimited Documents from Trusted Public Sources

Amicus - Company Report, October 2014

  • Amicus Therapeutics Announces Additional Positive Phase 3 Data f...
  • October 2014
    3 pages
  • Therapy  

    Therapeutics  

  • United States  

View report >

Therapy Markets In The Us

September 2014

Vaccine Supply In Europe

September 2014

43 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

Biogen Idec

United States

Merck KGaA

Germany

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.